UC Davis Comprehensive Cancer Center hematologist Brian Jonas has earned the National Cancer Institute (NCI) Research Specialist Award (R50) to further his leadership in NCI-funded cancer research and clinical trials. This award supports exceptional scientists in advancing their careers by pursuing cancer research opportunities.
Jonas is a professor of medicine in the Division of Malignant Hematology, Cellular Therapy and Transplantation in the Department of Internal Medicine. His vision is to transform clinical care and research on blood cancer disorders, especially acute myeloid leukemia and myelodysplastic syndrome.
As the chair of the Data and Safety Monitoring Committee at the cancer center, Jonas contributes to clinical trial infrastructure, and ensures the highest quality and accountability in trials. He also is chair of the Hematology Disease Team Committee and oversees the management of the malignant hematology clinical trial portfolio, including several NCI-funded trials.
